Mild depression in primary care: do antidepressants add any effect to usual consultations?
ISRCTN | ISRCTN03007807 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN03007807 |
Secondary identifying numbers | NTR178; OOG00-020 |
- Submission date
- 20/12/2005
- Registration date
- 20/12/2005
- Last edited
- 06/07/2009
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Hein Hout, van
Scientific
Scientific
VU University Medical Centre
EMGO-Institute
Department of General Practice
Van der Boechorststraat 7
Amsterdam
1081 BT
Netherlands
Study information
Study design | Multicentre, randomised, active controlled, parallel group trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | GP practice |
Study type | Treatment |
Scientific title | |
Study acronym | HOMiD |
Study objectives | Antidepressant medication does not add any effect to usual consultations by general practitioners in patients with minor and mild-major depression |
Ethics approval(s) | Received from local medical ethics committee |
Health condition(s) or problem(s) studied | Depression |
Intervention | Patients were randomly assigned to four sessions of counselling during 3 months with (n=85) or without paroxetine (n=96). Both treatments were carried out by the patients own GP. |
Intervention type | Drug |
Pharmaceutical study type(s) | |
Phase | Not Specified |
Drug / device / biological / vaccine name(s) | paroxetine |
Primary outcome measure | 1. Severity of Depressive by MADRS (Montgomery Åsberg Depression Rating Scale) 2. Remission of depression by MADRS score<10 |
Secondary outcome measures | 1. Quality of Live (Short Form 36) 2. Subjective depression (Beck Depression. Inventory) 3. Client Satisfaction Questionnaire 4. Direct and indirect costs |
Overall study start date | 01/01/2002 |
Completion date | 01/05/2005 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | 181 |
Key inclusion criteria | 1. Aged 18 years or over 2. Having 3-6 out of 9 depressive symptoms for at least 2 weeks for most days of the week, including at least one of the core symptoms sadness or loss of pleasure. Impairment by depressive symptoms in social, occupational or other important areas of functioning (minor depression=3-4 symptoms, mild-major depression=5-6 symptoms) |
Key exclusion criteria | 1. Current intake of antidepressants or receiving psychological therapy 2. Psychotic features 3. Alcohol or drug addiction 4. Loss of a loved one or significant other in the past six months 5. Pregnancy or breastfeeding 6. Inability to complete questionnaires because of language difficulties, illiteracy or cognitive decline 7. Not having a telephone |
Date of first enrolment | 01/01/2002 |
Date of final enrolment | 01/05/2005 |
Locations
Countries of recruitment
- Netherlands
Study participating centre
VU University Medical Centre,
Amsterdam
1081 BT
Netherlands
1081 BT
Netherlands
Sponsor information
EMGO Institute (Netherlands)
Not defined
Not defined
Van der Boechorststraat 7
Amsterdam
1081 BT
Netherlands
Phone | +31 20 4448180 |
---|---|
emgo@vumc.nl | |
https://ror.org/0258apj61 |
Funders
Funder type
Government
The Health Care Insurance Board (CVZ) (Netherlands)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
Results article | results | 07/12/2007 | Yes | No |